Activating somatic mutations outside the SH2-domain of STAT3 in LGL leukemia.
Open Access
- 30 September 2015
- journal article
- letter
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 30 (5), 1204-8
- https://doi.org/10.1038/leu.2015.263
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- A Novel Missense (M206K) STAT3 Mutation in Diffuse Large B Cell Lymphoma Deregulates STAT3 SignalingPLOS ONE, 2013
- Discovery of somatic STAT5b mutations in large granular lymphocytic leukemiaBlood, 2013
- STAT3 mutations are frequent in CD30+ T-cell lymphomas and T-cell large granular lymphocytic leukemiaLeukemia, 2013
- STAT3 mutations are highly specific for large granular lymphocytic leukemiaLeukemia, 2012
- STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemiaBlood, 2012
- SomaticSTAT3Mutations in Large Granular Lymphocytic LeukemiaNew England Journal of Medicine, 2012
- Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomasThe Journal of Experimental Medicine, 2011
- Large granular lymphocyte leukemiaCurrent Hematologic Malignancy Reports, 2007
- Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expressionJCI Insight, 2001
- The Coiled-Coil Domain of Stat3 Is Essential for Its SH2 Domain-Mediated Receptor Binding and Subsequent Activation Induced by Epidermal Growth Factor and Interleukin-6Molecular and Cellular Biology, 2000